Therapeutics Company Eligible For Up to $330 Million on Successful Achievement of Prespecified Regulatory
$ADXN - Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration.
Disclaimer: The information presented in this article is intended for informational purposes only and should not be construed as professional medical advice or an endorsement of any specific treatments or therapies. Readers should consult healthcare professionals for advice related to their medical conditions.
We are working endle…